David Hagerty
9Patents
6h-index
9Co-inventors
52Inventor score
Filing activity: Jul 2, 2001 → Feb 19, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7455835B2 | Methods for treating immune system diseases using a soluble CTLA4 molecule | Chemistry; Metallurgy | 43 | Expired |
| US7482327B2 | Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules | Chemistry; Metallurgy | 17 | Expired |
| US8497247B2 | Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 11 | Active |
| US8227420B2 | Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID | Chemistry; Metallurgy | 9 | Active |
| US8148332B2 | Method for treating a rheumatic disease using a soluble TLA4 molecule | Chemistry; Metallurgy | 8 | Active |
| US8722632B2 | Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 7 | Active |
| US9296808B2 | Methods for treating scleroderma by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 5 | Active |
| US8703718B2 | Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 5 | Active |
| US10052360B2 | Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.